MFA
BSX icon

Mayflower Financial Advisors’s Boston Scientific BSX Stock Holding History

Mayflower Financial Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,156
Closed -$206K – 449
2025
Q4 		$206K Buy
+2,156
New +$211K 0.02% 400

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Mayflower Financial Advisors's BSX Position: Q1 2026 in Review

Mayflower Financial Advisors sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 2,156 shares — an estimated $206K sold.

Mayflower Financial Advisors first reported a position in BSX in Q4 2025 and held it in 1 quarter. The position peaked at $206K in Q4 2025. 1,671 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Mayflower Financial Advisors reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • Mayflower Financial Advisors sold 2,156 Boston Scientific shares in Q1 2026, an estimated $206K.
  • Mayflower Financial Advisors first reported a position in Boston Scientific in Q4 2025 and held it in 1 quarter.
  • Mayflower Financial Advisors's Boston Scientific position peaked at $206K in Q4 2025.
  • 1,671 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Mayflower Financial Advisors's 13F filing for Q1 2026, filed 23 Apr 2026.